FindTrial
Sign In

Efficacy of Guda-Ardrak Nasya in Vataja Pratishyaya Allergic Rhinitis A Randomized Controlled Clinical Trial

Effect of Gudaardrak nasya in the Management of Vataja Pratishyaya with special reference to Allergic Rhinitis A Randomised Controlled Clinical Trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086243
Enrollment
104
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Dr Adeeb A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling the diagnostic criteria of Vataja Pratishyaya (Allergic Rhinitis) Subjects fit for Nasya karma Subjects with signs & symptoms of Vataja Pratishyaya ,who are willing to enrol in the study by giving written consent

Exclusion criteria

Exclusion criteria: Nasal polyps (anterior rhinoscopy & probe test ) Any abnormal nasal growth like Rhinoporidiosis, Rhinolith Epistaxis D.N.S. grade 1 (with anterior rhinoscopy) Tumours of the nose Acute Upper respiratory tract infection. Other Systemic Disorders like Tuberculosis, Leprosy, uncontrolled DM and hypertension

Design outcomes

Primary

MeasureTime frame
Changes in reduction of prstishyaya lakshana like Nasavarodha Nasasrava Kshavathu Shirashoola Toda in Nasa Akshi Gala and Talu Kandu in Nasa Akshi Gala and TaluTimepoint: 1st day Before treatment 30th day after treatment and 60th day follow up—

Secondary

MeasureTime frame
Changes in AECTimepoint: Baseline 1st day to 30th day after tretament—

Countries

India

Contacts

Public ContactDr Savita S Angadi

KAHERs SBM Kankanawadi Ayurveda Mahavidyalaya

savitaangadi.kaher@kleayurworld.edu.in74111213286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026